BGI Genomics Co., Ltd. (SHE:300676)
China · Delayed Price · Currency is CNY 38.12
+1.20 (3.25%)
Nov 2, 2026, 3:04 PM CST
BGI Genomics Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 2,650 | 3,286 | 3,935 | 4,732 | 5,160 | 6,590 |
Short-Term Investments | - | - | - | 23.28 | 11.2 | 6.57 |
Trading Asset Securities | 511.51 | 492.42 | 375.12 | 753.58 | 1,232 | 2,049 |
Cash & Short-Term Investments | 3,162 | 3,778 | 4,310 | 5,509 | 6,403 | 8,646 |
Cash Growth | -14.45% | -12.34% | -21.77% | -13.96% | -25.94% | 59.22% |
Accounts Receivable | 1,759 | 1,665 | 1,679 | 1,464 | 2,223 | 1,244 |
Other Receivables | 52.34 | 75.77 | 73.24 | 54.22 | 174.47 | 49.74 |
Receivables | 1,812 | 1,741 | 1,752 | 1,518 | 2,397 | 1,294 |
Inventory | 538.2 | 480.2 | 601.62 | 602.18 | 717.83 | 877.72 |
Other Current Assets | 143.38 | 150.91 | 212.07 | 303.49 | 257.24 | 217.2 |
Total Current Assets | 5,655 | 6,150 | 6,876 | 7,933 | 9,775 | 11,035 |
Property, Plant & Equipment | 2,642 | 2,766 | 2,854 | 3,190 | 2,191 | 1,400 |
Long-Term Investments | 1,426 | 1,436 | 1,306 | 1,252 | 1,328 | 898.21 |
Goodwill | 36.47 | 36.47 | 36.47 | 47.11 | 47.11 | 47.11 |
Other Intangible Assets | 384.79 | 406.53 | 359.6 | 418.82 | 410.89 | 245.46 |
Long-Term Deferred Tax Assets | 250.26 | 236.02 | 230.47 | 241.58 | 236.29 | 200.29 |
Long-Term Deferred Charges | 129.95 | 157.38 | 299.14 | 362.86 | 209.51 | 177.65 |
Other Long-Term Assets | 578.88 | 561.2 | 580.15 | 167.17 | 187.25 | 250.86 |
Total Assets | 11,104 | 11,749 | 12,542 | 13,613 | 14,385 | 14,254 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 719.18 | 847.12 | 1,137 | 864.6 | 1,025 | 805.32 |
Accrued Expenses | 59.88 | 813.66 | 799.98 | 668.29 | 958.97 | 653.08 |
Short-Term Debt | - | - | 24.91 | - | - | 5.01 |
Current Portion of Long-Term Debt | 80.1 | 88.9 | 31.23 | 24.18 | - | 35.74 |
Current Portion of Leases | - | 31.67 | 26.32 | 57.79 | 63.33 | 90.6 |
Current Income Taxes Payable | 58.64 | 7.6 | 12.7 | 59.79 | 77.35 | 167.83 |
Current Unearned Revenue | 547.25 | 619.84 | 637.83 | 699.71 | 929.35 | 1,410 |
Other Current Liabilities | 532.88 | 128.13 | 172.17 | 922.68 | 901.93 | 216.41 |
Total Current Liabilities | 1,998 | 2,537 | 2,842 | 3,297 | 3,956 | 3,384 |
Long-Term Debt | 613.47 | 442.82 | 339.11 | 215.68 | - | 631.96 |
Long-Term Leases | 27.19 | 73.47 | 49.7 | 67.75 | 136.68 | 84.44 |
Long-Term Unearned Revenue | 99.14 | 70.45 | 15.11 | 15.39 | 19.68 | 36.07 |
Long-Term Deferred Tax Liabilities | 16.74 | 16.42 | 24.89 | 13.13 | 51.56 | 5.19 |
Other Long-Term Liabilities | - | 1.45 | - | - | - | 671.57 |
Total Liabilities | 2,754 | 3,142 | 3,271 | 3,609 | 4,164 | 4,813 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 418.32 | 418.32 | 415.82 | 413.91 | 413.91 | 413.91 |
Additional Paid-In Capital | 4,794 | 4,771 | 4,762 | 4,592 | 4,680 | 4,657 |
Retained Earnings | 3,316 | 3,266 | 3,882 | 4,826 | 5,147 | 4,488 |
Treasury Stock | -250.6 | -57.61 | -99.92 | -115.32 | -336.75 | -87.95 |
Comprehensive Income & Other | -38.17 | 96.31 | 175.21 | 143.11 | 172 | -152.57 |
Total Common Equity | 8,239 | 8,494 | 9,135 | 9,859 | 10,076 | 9,318 |
Minority Interest | 110.08 | 113.49 | 136.75 | 144.78 | 145.09 | 122.87 |
Shareholders' Equity | 8,349 | 8,608 | 9,272 | 10,004 | 10,221 | 9,441 |
Total Liabilities & Equity | 11,104 | 11,749 | 12,542 | 13,613 | 14,385 | 14,254 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 720.76 | 636.85 | 471.27 | 365.4 | 200.01 | 847.75 |
Net Cash (Debt) | 2,441 | 3,141 | 3,838 | 5,144 | 6,203 | 7,798 |
Net Cash Growth | -19.45% | -18.17% | -25.38% | -17.07% | -20.46% | 89.68% |
Net Cash Per Share | 5.87 | 7.54 | 9.31 | 12.47 | 15.12 | 18.94 |
Filing Date Shares Outstanding | 409.81 | 417.02 | 412.38 | 379.44 | 409.91 | 409.91 |
Total Common Shares Outstanding | 409.81 | 417.02 | 412.38 | 379.44 | 409.91 | 409.91 |
Working Capital | 3,657 | 3,613 | 4,034 | 4,636 | 5,819 | 7,651 |
Book Value Per Share | 20.11 | 20.37 | 22.15 | 25.98 | 24.58 | 22.73 |
Tangible Book Value | 7,818 | 8,051 | 8,739 | 9,393 | 9,618 | 9,026 |
Tangible Book Value Per Share | 19.08 | 19.31 | 21.19 | 24.76 | 23.46 | 22.02 |
Buildings | - | 1,923 | 1,782 | 1,787 | 490.05 | 418.81 |
Machinery | - | 2,509 | 2,362 | 2,195 | 1,841 | 1,612 |
Construction In Progress | - | 10.73 | 205.67 | 418.08 | 752.33 | 38.5 |